This test is most useful if any of these apply to you.
This is one of the so-called forever chemicals, and once it gets into your blood it can stay there for years. Testing it tells you something a standard checkup never will: how much of a persistent industrial pollutant your body is carrying right now.
That matters because higher levels have been tied to fatty liver, pregnancy complications, and shifts in immune and metabolic markers. Knowing your number is the first step to figuring out where your exposure is coming from and whether it is worth reducing.
PFHxS (perfluorohexane sulfonic acid) belongs to a family of thousands of synthetic compounds called PFAS (per- and polyfluoroalkyl substances), prized in industry because they repel water, grease, and heat. Your body does not make it and has no use for it. Every molecule in your blood got there from the outside world, mostly through what you eat and drink.
Once absorbed, this chemical is not broken down the way most substances are. It travels through the blood stuck mainly to your most abundant blood protein (albumin), and possibly to a fat-carrying protein in the liver, which is why it is measured in serum or plasma rather than being flushed out quickly. It is common enough that recent surveys detect it in more than 95% of people tested.
Because it is an exposure marker and not something your organs produce, there is no such thing as a "deficiency." A low level simply means a smaller stored burden. A high level means your body has taken in and held onto more of this pollutant than most people, usually over a long stretch of time.
For most people, food and drinking water are the main routes in. Levels climb sharply in communities whose water has been contaminated, especially near airfields and fire-training sites where firefighting foam was used for decades. In one heavily exposed Swedish town, blood levels ran far above the national background and stayed elevated for years after the water was cleaned up.
Indoor and consumer sources add to the everyday background. These chemicals have been used in stain-resistant carpet and upholstery, water-repellent clothing, grease-resistant food packaging, and non-stick coatings, and household dust carries traces of them. In a national survey, people with wall-to-wall low-pile carpet had higher blood levels than those without.
The most consistent signal in the human research is liver-related. In a study of about 1,100 US adults, each step up in blood level was linked to roughly 13% higher odds of fatty liver disease, a condition where fat builds up inside the liver (odds ratio 1.13). The link was stronger in people who were obese, drank heavily, or ate a high-fat diet.
Among heavy drinkers specifically, higher levels tracked with about twice the odds of alcohol-related fatty liver (odds ratio 2.06). A separate study tied higher levels to a marker of liver cells dying off, suggesting real liver stress rather than a coincidence.
Metabolic links show up elsewhere too, though they are more preliminary. In overweight Hispanic children, higher levels predicted worse blood sugar control, including a roughly 10 mg/dL rise in two-hour glucose. In adults with prediabetes, higher levels tracked with higher cholesterol and predicted later abnormal lipids.
What this means for you: if your level is elevated and you already carry liver or metabolic risk factors, it is a reason to pay closer attention to standard liver enzymes, lipids, and blood sugar, not a diagnosis on its own.
The clearest pregnancy signal is for preeclampsia, a dangerous rise in blood pressure during pregnancy. In a Canadian cohort of over 1,700 women, each doubling of the blood level was tied to about 32% higher odds of preeclampsia, and women in the highest third had roughly three times the odds of those in the lowest third.
That finding does not repeat everywhere. A large study in a highly exposed Swedish population found no increase in pregnancy-related high blood pressure or gestational diabetes, and a Danish cohort found no clear preeclampsia link. The honest read is that the pregnancy evidence points in a concerning direction but is not settled.
One thing is not in doubt: this chemical crosses the placenta efficiently. In an exposed mother-child cohort it had the highest transfer rate of the PFAS measured, meaning a mother's stored burden reaches the developing baby. For anyone pregnant or planning to be, that makes exposure worth understanding early.
Higher levels have been linked to shifts in the immune system. In women, higher levels tracked with changes in signaling proteins that regulate immune activity. In a very large analysis of adults, levels were associated with small changes in the number of infection-fighting white blood cells, including T, B, and natural killer cells.
Whether these shifts translate into real illness is less clear, but there is at least one clinical hint. In US children and teens, each doubling of the blood level was tied to about 31% higher odds of having had a recent common cold, consistent with a mild dampening of immune defense.
Cancer evidence is inconsistent and should be read with caution. One large cohort found a link between higher levels and chronic lymphocytic leukemia and small lymphocytic lymphoma in men, both cancers of the same white blood cell type. Analyses of national survey data have flagged possible links to melanoma and brain cancer, but these are exploratory and need replication.
Thyroid cancer is where the picture gets confusing. One recent study found higher exposure in people with thyroid tumors, while a large study using blood drawn before diagnosis found the opposite, with higher levels linked to lower thyroid cancer risk. This is not a simple higher-is-worse marker; it is a stamp of cumulative exposure, and different study designs, populations, and cancers can pull the association in opposite directions. The sensible interpretation is that the cancer links remain unproven, not that the chemical protects against anything.
This chemical moves slowly. Human half-lives, the time for the level to drop by half once exposure stops, generally fall in the range of about 2.84 to 8.5 years, with community estimates around 5 years and pooled modeling landing near 8 years. A single reading therefore reflects years of accumulated exposure, not what you ate or drank last week.
That slow pace is exactly why tracking is useful. If you identify and remove an exposure source, a follow-up test roughly a year later can show whether your level is actually falling, since the drop is gradual and easy to miss over shorter intervals. A practical plan is a baseline now, a repeat in about 12 months if you are making changes or have a known exposure, and periodic checks after that.
Because there are no standardized clinical cutpoints for this marker, your own trajectory is the most useful thing you can build. Getting a baseline while the science is still developing gives you a personal reference point to compare against as thresholds and guidance mature.
An elevated level is a prompt to find the source, not a diagnosis. The first practical step is to check your water: if you rely on a private well or live near a known contamination site, testing your drinking water is often the highest-yield move. Firefighters and others with occupational exposure already have a likely explanation.
Pair the result with companion labs that reveal whether any associated biology is showing up. Liver enzymes, a lipid panel, fasting glucose or HbA1c, and a kidney assessment together sketch the domains where higher levels have been linked to changes. For a markedly high level, especially in pregnancy or with heavy occupational exposure, a clinician or medical toxicology specialist can help place the number in context and decide whether any action beyond exposure reduction is warranted.
Evidence-backed interventions that affect your PFHxS level
PFHxS is best interpreted alongside these tests.
PFHxS is included in these pre-built panels.